Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience

作者: Yusuke Kondo , Markus Linhart , René P. Andrié , Joerg O. Schwab

DOI: 10.1016/J.JOA.2015.03.007

关键词:

摘要: Background The effectiveness of the wearable cardioverter defibrillator (WCD) therapy in early post-myocardial infarction (MI) patients remains uncertain.

参考文章(13)
Helmut U. Klein, Ilan Goldenberg, Arthur J. Moss, Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator European Heart Journal. ,vol. 34, pp. 2230- 2242 ,(2013) , 10.1093/EURHEARTJ/EHT167
Akihiko Shimizu, Takashi Nitta, Takashi Kurita, Katsuhiko Imai, Yoshinori Kobayashi, Kyouko Soejima, Shinnichi Niwano, Shigeyuki Watanabe, Harushiko Abe, Yoshifusa Aizawa, Ken Okumura, Actual conditions of implantable defibrillation therapy over 5 years in Japan Journal of Arrhythmia. ,vol. 28, pp. 263- 272 ,(2012) , 10.1016/J.JOA.2012.03.014
Arnon Adler, Amir Halkin, Sami Viskin, Wearable Cardioverter-Defibrillators Circulation. ,vol. 127, pp. 854- 860 ,(2013) , 10.1161/CIRCULATIONAHA.112.146530
Gerhard Steinbeck, Dietrich Andresen, Karlheinz Seidl, Johannes Brachmann, Ellen Hoffmann, Dariusz Wojciechowski, Zdzisława Kornacewicz-Jach, Beata Sredniawa, Géza Lupkovics, Franz Hofgärtner, Andrzej Lubinski, Mårten Rosenqvist, Alphonsus Habets, Karl Wegscheider, Jochen Senges, Defibrillator implantation early after myocardial infarction. The New England Journal of Medicine. ,vol. 361, pp. 1427- 1436 ,(2009) , 10.1056/NEJMOA0901889
Andrew E Epstein, John P DiMarco, Kenneth A Ellenbogen, NA Mark Estes III, Roger A Freedman, Leonard S Gettes, A Marc Gillinov, Gabriel Gregoratos, Stephen C Hammill, David L Hayes, Mark A Hlatky, L Kristin Newby, Richard L Page, Mark H Schoenfeld, Michael J Silka, Lynne Warner Stevenson, Michael O Sweeney, None, 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. ,vol. 127, ,(2013) , 10.1161/CIR.0B013E318276CE9B
Akihiko Shimizu, How Should We Use the Wearable Cardioverter-Defibrillator in Japan? Circulation. ,vol. 78, pp. 2851- 2853 ,(2014) , 10.1253/CIRCJ.CJ-14-1188
Andrew E Epstein, William T Abraham, Nicole R Bianco, Karl B Kern, Michael Mirro, Sunil V Rao, Edward K Rhee, Scott D Solomon, Steven J Szymkiewicz, None, Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction Journal of the American College of Cardiology. ,vol. 62, pp. 2000- 2007 ,(2013) , 10.1016/J.JACC.2013.05.086
Gust H. Bardy, Kerry L. Lee, Daniel B. Mark, Jeanne E. Poole, Douglas L. Packer, Robin Boineau, Michael Domanski, Charles Troutman, Jill Anderson, George Johnson, Steven E. McNulty, Nancy Clapp-Channing, Linda D. Davidson-Ray, Elizabeth S. Fraulo, Daniel P. Fishbein, Richard M. Luceri, John H. Ip, Amiodarone or an implantable cardioverter-defibrillator for congestive Heart failure The New England Journal of Medicine. ,vol. 352, pp. 225- 237 ,(2005) , 10.1056/NEJMOA043399
Stefan H. Hohnloser, Karl Heinz Kuck, Paul Dorian, Robin S. Roberts, John R. Hampton, Robert Hatala, Eric Fain, Michael Gent, Stuart J. Connolly, Prophylactic Use of an Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction The New England Journal of Medicine. ,vol. 351, pp. 2481- 2488 ,(2004) , 10.1056/NEJMOA041489